Microemboli may link spreading depression, migraine aura, and patent foramen ovale

Annals of Neurology

Volumn 67, Issue 2, 2010, Pages 221-229

  Nozari, Ala ^a   Dilekoz, Ergin ^a   Sukhotinsky, Inna ^a   Stein, Thor ^a   Eikermann Haerter, Katharina ^a   Liu, Christina ^a   Wang, Yumei ^a   Frosch, Matthew P ^a   Waeber, Christian ^a   Ayata, Cenk ^a   Moskowitz, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; MICROSPHERE; POLYSTYRENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EMBOLISM; BRAIN INFARCTION; BRAIN PERFUSION; CAROTID ARTERY FLOW; CONTROLLED STUDY; MICROEMBOLISM; MIGRAINE AURA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT FORAMEN OVALE; PRIORITY JOURNAL; SPREADING CORTICAL DEPRESSION;

ANIMALS; CEREBROVASCULAR CIRCULATION; CORTICAL SPREADING DEPRESSION; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EMBOLISM; FORAMEN OVALE, PATENT; FUNCTIONAL LATERALITY; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICROCIRCULATION; MIGRAINE WITH AURA; NEUROLOGIC EXAMINATION;

EID: 77949416784     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21871     Document Type: Article

References (45)

1. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-657.
2. Henrich JB, Horwitz RI. A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol 1989;42:773-780.
3. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005;330:63.
4. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984;16:157-168.
5. Leao AAP. Spreading depression of activity in the cerebral cortex. J. Neurophysiol 1944;7:359-390.
6. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001;98:4687-4692.
7. Andersen AR, Friberg L, Olsen TS, Olesen J. Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol 1988; 45:154-159.
8. Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-1692.
9. Matsushima K, Schmidt-Kastner R, Hogan MJ, Hakim AM. Cortical spreading depression activates trophic factor expression in neurons and astrocytes and protects against subsequent focal brain ischemia. Brain Res 1998;807:47-60.
10. Dohmen C, Sakowitz OW, Fabricius M, et al. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol 2008;63:720-728.
11. Dreier JP, Woitzik J, Fabricius M, et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006;129(pt 12): 3224-3237.
12. Strong AJ, Fabricius M, Boutelle MG, et al. Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke 2002;33:2738-2743.
13. Wolff H. Headache and Other Head Pain. New York, NY: Oxford University Press, 1963.
14. Van Harreveld A, Stamm J. Vascular concomitants of spreading cortical depression. J Neurophysiol 1952;15:487-496.
15. Olesen J, Friberg L, Olsen TS, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993;116(pt 1):187-202.
16. Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998;8:327-330.
17. Post MC, Letteboer TG, Mager JJ, et al. A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest 2005;128:2485-2489.
18. Rigatelli G. Migraine and patent foramen ovale: connecting flight or one-way ticket? Expert Rev Neurother 2008;8:1331-1337.
19. Nozari A, Dilekoz E, Sukhotinsky I, et al. Microembolization triggers cortical spreading depression both with and without microinfarcts: implications for a migraine-stroke continuum. Stroke 2009;40:P280.
20. Ayata C, Dunn AK, Gursoy-Ozdemir Y, Huang Z, Boas DA, Moskowitz MA. Laser speckle flowmetry for the study of cerebrovascular physiology in normal and ischemic mouse cortex. J Cereb Blood Flow Metab 2004;24:744-755.
21. Eikermann-Haerter K, Dilekoz E, Kudo C, et al. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 2009;119:99-109.
22. Weiss L, Harlos JP. The validity of negative necropsy reports for metastases in solid organs. J Pathol 1986;148:203-206.
23. Dinia L, Roccatagliata L, Bonzano L, et al. Diffusion MRI during migraine with aura attack associated with diagnostic microbubbles injection in subjects with large PFO. Headache 2007;47: 1455-1456.
24. Steiner TJ, Rail DL, Rose FC. Cholesterol crystal embolization in rat brain: a model for atheroembolic cerebral infarction. Stroke 1980;11:184-189.
25. Busch E, Gyngell ML, Eis M, Hoehn-Berlage M, Hossmann KA. Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging. J Cereb Blood Flow Metab 1996;16:1090-1099.
26. Hanington E, Jones RJ, Amess JA, Wachowicz B. Migraine: a platelet disorder. Lancet 1981;2:720-723.
27. Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 2002;33:706-711.
28. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
29. Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 2008;28:531-540.
30. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-1404.
31. Anzola GP, Magoni M, Guindani M, et al. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999;52:1622-1625.
32. Steiner MM, Di Tullio MR, Rundek T, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-948.
33. Dubiel M, Bruch L, Schmehl I, et al. Migraine headache relief after percutaneous transcatheter closure of interatrial communications. J Interv Cardiol 2008;21:32-37.
34. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004;62:1439-1440.
35. Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62:1399-1401.
36. Shammas NW, Dippel EJ, Harb G, et al. Interatrial septal defect closure for prevention of cerebrovascular accidents: impact on recurrence and frequency of migraine headaches. J Invasive Cardiol 2007;19:257-260.
37. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
38. Kruit MC, van Buchem MA, Hofman PAM, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
39. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005;128(pt 9):2068-2077.
40. Friberg L, Olsen TS, Roland PE, Lassen NA. Focal ischaemia caused by instability of cerebrovascular tone during attacks of hemiplegic migraine. A regional cerebral blood flow study. Brain 1987;110(pt 4):917-934.
41. Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 1994;15:149-153.
42. Michiels JJ, Berneman Z, Schroyens W, et al. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Platelets 2006;17:528-544.
43. Ayata C, Jin H, Kudo C, et al. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006;59:652-661.
44. Diener HC, Tfelt-Hansen P, Dahlof C, et al. Topiramate in migraine prophylaxis - results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004;251:943-950.
45. Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology 1994;44:647-651.